Filter News
Area of Research
- (-) Neutron Science (103)
- (-) Nuclear Science and Technology (19)
- (-) Supercomputing (88)
- Advanced Manufacturing (7)
- Biological Systems (2)
- Biology and Environment (127)
- Biology and Soft Matter (1)
- Clean Energy (105)
- Climate and Environmental Systems (5)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (26)
- Fusion Energy (13)
- Isotopes (24)
- Materials (103)
- Materials for Computing (13)
- Mathematics (1)
- National Security (14)
- Quantum information Science (9)
News Topics
- (-) Bioenergy (13)
- (-) Composites (1)
- (-) Environment (28)
- (-) Frontier (29)
- (-) Fusion (10)
- (-) Isotopes (6)
- (-) Mathematics (1)
- (-) Microscopy (8)
- (-) Neutron Science (102)
- (-) Quantum Science (29)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (12)
- Artificial Intelligence (39)
- Big Data (20)
- Biology (14)
- Biomedical (27)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (17)
- Computer Science (99)
- Coronavirus (17)
- Critical Materials (3)
- Cybersecurity (10)
- Decarbonization (7)
- Energy Storage (14)
- Exascale Computing (22)
- Fossil Energy (1)
- Grid (5)
- High-Performance Computing (39)
- Machine Learning (16)
- Materials (28)
- Materials Science (36)
- Molten Salt (5)
- Nanotechnology (19)
- National Security (8)
- Net Zero (1)
- Nuclear Energy (41)
- Partnerships (1)
- Physics (17)
- Polymers (3)
- Quantum Computing (19)
- Security (6)
- Simulation (14)
- Software (1)
- Space Exploration (10)
- Summit (42)
- Sustainable Energy (11)
- Transformational Challenge Reactor (3)
- Transportation (10)
Media Contacts
ORNL’s Fulvia Pilat and Karren More recently participated in the inaugural 2023 Nanotechnology Infrastructure Leaders Summit and Workshop at the White House.
In 2023, the National School on X-ray and Neutron Scattering, or NXS, marked its 25th year during its annual program, held August 6–18 at the Department of Energy’s Oak Ridge and Argonne National Laboratories.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
As Frontier, the world’s first exascale supercomputer, was being assembled at the Oak Ridge Leadership Computing Facility in 2021, understanding its performance on mixed-precision calculations remained a difficult prospect.
Researchers from Oak Ridge National Laboratory and Northeastern University modeled how extreme conditions in a changing climate affect the land’s ability to absorb atmospheric carbon — a key process for mitigating human-caused emissions. They found that 88% of Earth’s regions could become carbon emitters by the end of the 21st century.
Neutron experiments can take days to complete, requiring researchers to work long shifts to monitor progress and make necessary adjustments. But thanks to advances in artificial intelligence and machine learning, experiments can now be done remotely and in half the time.
Outside the high-performance computing, or HPC, community, exascale may seem more like fodder for science fiction than a powerful tool for scientific research. Yet, when seen through the lens of real-world applications, exascale computing goes from ethereal concept to tangible reality with exceptional benefits.
A new nanoscience study led by a researcher at ORNL takes a big-picture look at how scientists study materials at the smallest scales.
A group at the Department of Energy's Oak Ridge National Laboratory made a difference for local youth through hands-on projects that connected neutron science and engineering intuitively.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.